Comorbidities in Patients with Crystal Diseases and Hyperuricemia

Overview

Journal Rheum Dis Clin North Am

Publisher Elsevier

Specialty Rheumatology

Date 2014 Apr 8

PMID 24703346

Citations 19

Authors

Sebastian E Sattui

Jasvinder A Singh

Angelo L Gaffo

Affiliations

Soon will be listed here.

Abstract

Crystal arthropathies are among the most common causes of painful inflammatory arthritis. Gout, the most common example, has been associated with cardiovascular and renal disease. In recent years, evidence for these associations and those involving other comorbidities, such as the metabolic syndrome, have emerged, and the importance of asymptomatic hyperuricemia has been established. In this review, an update on evidence, both experimental and clinical, is presented, and associations between hyperuricemia, gout, and several comorbidities are described. Causality regarding calcium pyrophosphate arthropathy and associated comorbidities is also reviewed.

Citing Articles

Asymptomatic hyperuricaemia in chronic kidney disease: mechanisms and clinical implications.

Anders H, Li Q, Steiger S Clin Kidney J. 2023; 16(6):928-938.

PMID: 37261000 PMC: 10229286. DOI: 10.1093/ckj/sfad006.

Activation of NRF2 Signaling Pathway Delays the Progression of Hyperuricemic Nephropathy by Reducing Oxidative Stress.

Qiao P, Sun Y, Wang Y, Lin S, An Y, Wang L Antioxidants (Basel). 2023; 12(5).

PMID: 37237889 PMC: 10215166. DOI: 10.3390/antiox12051022.

Synovium to Myocardium: A Case of Calcium Pyrophosphate Dihydrate Crystal Arthritis Associated With Myocardial Infarction.

Raza M, Rana M, Arif M, Akinpelu T, Waheed A Cureus. 2023; 15(2):e34528.

PMID: 36879710 PMC: 9984863. DOI: 10.7759/cureus.34528.

Prevalence and Risk Factors of Hyperuricemia and Gout: A Cross-sectional Survey from 31 Provinces in Mainland China.

Song J, Jin C, Shan Z, Teng W, Li J J Transl Int Med. 2022; 10(2):134-145.

PMID: 35959454 PMC: 9328039. DOI: 10.2478/jtim-2022-0031.

Hyperuricemia Is Associated with Significant Liver Fibrosis in Subjects with Nonalcoholic Fatty Liver Disease, but Not in Subjects without It.

Yen P, Chou Y, Li C, Sun Z, Wu C, Chang Y J Clin Med. 2022; 11(5).

PMID: 35268536 PMC: 8911142. DOI: 10.3390/jcm11051445.

References

Duan W, Ladenheim B, Cutler R, Kruman I, Cadet J, Mattson M . Dietary folate deficiency and elevated homocysteine levels endanger dopaminergic neurons in models of Parkinson's disease. J Neurochem. 2002; 80(1):101-10. DOI: 10.1046/j.0022-3042.2001.00676.x. View

George J, Carr E, Davies J, Belch J, Struthers A . High-dose allopurinol improves endothelial function by profoundly reducing vascular oxidative stress and not by lowering uric acid. Circulation. 2006; 114(23):2508-16. DOI: 10.1161/CIRCULATIONAHA.106.651117. View

Ciancio G, Bortoluzzi A, Govoni M . Epidemiology of gout and chondrocalcinosis. Reumatismo. 2012; 63(4):207-20. DOI: 10.4081/reumatismo.2011.207. View

Sanchez-Lozada L, Tapia E, Jimenez A, Bautista P, Cristobal M, Nepomuceno T . Fructose-induced metabolic syndrome is associated with glomerular hypertension and renal microvascular damage in rats. Am J Physiol Renal Physiol. 2006; 292(1):F423-9. DOI: 10.1152/ajprenal.00124.2006. View

Rho Y, Zhu Y, Choi H . The epidemiology of uric acid and fructose. Semin Nephrol. 2011; 31(5):410-9. PMC: 3197219. DOI: 10.1016/j.semnephrol.2011.08.004. View

Krishnan E . Gout and the risk for incident heart failure and systolic dysfunction. BMJ Open. 2012; 2(1):e000282. PMC: 3282286. DOI: 10.1136/bmjopen-2011-000282. View

Khan F, George J, Wong K, McSwiggan S, Struthers A, Belch J . Allopurinol treatment reduces arterial wave reflection in stroke survivors. Cardiovasc Ther. 2008; 26(4):247-52. DOI: 10.1111/j.1755-5922.2008.00057.x. View

Grayson P, Kim S, LaValley M, Choi H . Hyperuricemia and incident hypertension: a systematic review and meta-analysis. Arthritis Care Res (Hoboken). 2010; 63(1):102-10. PMC: 3016454. DOI: 10.1002/acr.20344. View

Sanchez-Lozada L, Tapia E, Bautista-Garcia P, Soto V, Avila-Casado C, Vega-Campos I . Effects of febuxostat on metabolic and renal alterations in rats with fructose-induced metabolic syndrome. Am J Physiol Renal Physiol. 2008; 294(4):F710-8. DOI: 10.1152/ajprenal.00454.2007. View

10.

Jalal D, Rivard C, Johnson R, Maahs D, McFann K, Rewers M . Serum uric acid levels predict the development of albuminuria over 6 years in patients with type 1 diabetes: findings from the Coronary Artery Calcification in Type 1 Diabetes study. Nephrol Dial Transplant. 2010; 25(6):1865-9. PMC: 2902891. DOI: 10.1093/ndt/gfp740. View

11.

Momeni A, Shahidi S, Seirafian S, Taheri S, Kheiri S . Effect of allopurinol in decreasing proteinuria in type 2 diabetic patients. Iran J Kidney Dis. 2010; 4(2):128-32. View

12.

Kim S, Guevara J, Kim K, Choi H, Heitjan D, Albert D . Hyperuricemia and risk of stroke: a systematic review and meta-analysis. Arthritis Rheum. 2009; 61(7):885-92. PMC: 2714267. DOI: 10.1002/art.24612. View

13.

Richette P, Bardin T, Doherty M . An update on the epidemiology of calcium pyrophosphate dihydrate crystal deposition disease. Rheumatology (Oxford). 2009; 48(7):711-5. DOI: 10.1093/rheumatology/kep081. View

14.

Siu Y, Leung K, Ka-Hang Tong M, Kwan T . Use of allopurinol in slowing the progression of renal disease through its ability to lower serum uric acid level. Am J Kidney Dis. 2005; 47(1):51-9. DOI: 10.1053/j.ajkd.2005.10.006. View

15.

Cohen A, Aberdroth R, Hochstein P . Inhibition of free radical-induced DNA damage by uric acid. FEBS Lett. 1984; 174(1):147-50. DOI: 10.1016/0014-5793(84)81094-7. View

16.

Dawson J, Quinn T, Harrow C, Lees K, Walters M . The effect of allopurinol on the cerebral vasculature of patients with subcortical stroke; a randomized trial. Br J Clin Pharmacol. 2009; 68(5):662-8. PMC: 2791972. DOI: 10.1111/j.1365-2125.2009.03497.x. View

17.

Kanbay M, Huddam B, Azak A, Solak Y, Kadioglu G, Kirbas I . A randomized study of allopurinol on endothelial function and estimated glomular filtration rate in asymptomatic hyperuricemic subjects with normal renal function. Clin J Am Soc Nephrol. 2011; 6(8):1887-94. PMC: 3359530. DOI: 10.2215/CJN.11451210. View

18.

Masuo K, Kawaguchi H, Mikami H, Ogihara T, Tuck M . Serum uric acid and plasma norepinephrine concentrations predict subsequent weight gain and blood pressure elevation. Hypertension. 2003; 42(4):474-80. DOI: 10.1161/01.HYP.0000091371.53502.D3. View

19.

Ioachimescu A, Brennan D, Hoar B, Kashyap S, Hoogwerf B . Serum uric acid, mortality and glucose control in patients with Type 2 diabetes mellitus: a PreCIS database study. Diabet Med. 2007; 24(12):1369-74. DOI: 10.1111/j.1464-5491.2007.02302.x. View

20.

Alvarez-Nemegyei J, Medina-Escobedo M, Villanueva-Jorge S, Vazquez-Mellado J . Prevalence and risk factors for urolithiasis in primary gout: is a reappraisal needed?. J Rheumatol. 2005; 32(11):2189-91. View